This supports suggestions that there may be a distinct association between APOE expression, and thus ApoE synthesis, in malignant ovarian tissue and estrogens [182], yet, thus far, there is no strong evidence from GWAS of ovarian cancer that APOE variation may contribute to this or pose a significant or clear increase in risk [183,184,185]. The gene discussed is APOE; the disease is ovarian cancer.